BARTALENA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 1.197
EU - Europa 548
AS - Asia 155
AF - Africa 69
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.972
Nazione #
US - Stati Uniti d'America 1.160
SE - Svezia 215
IT - Italia 110
DE - Germania 69
SG - Singapore 58
BG - Bulgaria 48
CI - Costa d'Avorio 44
CN - Cina 43
CA - Canada 37
GB - Regno Unito 30
SN - Senegal 22
TR - Turchia 16
IN - India 15
FI - Finlandia 13
RU - Federazione Russa 13
FR - Francia 12
VN - Vietnam 12
AT - Austria 10
UA - Ucraina 9
BE - Belgio 8
HK - Hong Kong 6
RO - Romania 4
CH - Svizzera 3
NG - Nigeria 2
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
Totale 1.972
Città #
Woodbridge 174
Chandler 172
Fairfield 116
Houston 100
Ashburn 77
Ann Arbor 74
New York 49
Sofia 48
Wilmington 46
Abidjan 44
Cambridge 44
Seattle 42
Ottawa 37
Florence 31
Serra 26
Frankfurt am Main 24
Lawrence 24
Princeton 24
Dakar 22
Dearborn 21
Medford 20
Pisa 15
Singapore 15
Bremen 13
Izmir 12
London 12
Lancaster 11
Marseille 11
Des Moines 9
Vienna 9
Ogden 8
Düsseldorf 7
Los Angeles 7
San Diego 7
Beijing 6
Hebei 5
Jacksonville 5
Jüchen 5
Brussels 4
Changsha 4
Dong Ket 4
Hong Kong 4
Milan 4
Nanchang 4
Nanjing 4
Guangzhou 3
Jiaxing 3
Kilburn 3
Kunming 3
Livorno 3
Augusta 2
Bucharest 2
Egg 2
Grafing 2
Hangzhou 2
Horia 2
Istanbul 2
Jinan 2
Kocaeli 2
Lagos 2
Mainz 2
Northbrook 2
Norwalk 2
Pune 2
Redwood City 2
Senigallia 2
Washington 2
Ambato 1
Bern 1
Boardman 1
Brno 1
Buffalo 1
Central 1
Chehalis 1
Diss 1
Edinburgh 1
Empoli 1
Helsinki 1
Hyderabad 1
Islamabad 1
Kowloon 1
Madrid 1
Mapo-gu 1
Orange 1
Osaka 1
Redmond 1
Rome 1
San Jose 1
San Mateo 1
Shaoxing 1
Shenyang 1
Simi Valley 1
Stockholm 1
Tappahannock 1
Torino 1
Valdivia 1
Vicopisano 1
Wiesbaden 1
Zhengzhou 1
Totale 1.481
Nome #
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 145
REGULATION OF CARDIAC FATTY ACID METABOLISM IN TRANSGENIC MICE OVEREXPRESSING BOVINE GROWTH HORMONE 132
TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease 132
Use of solubilized radioiodinated thyroid plasma membranes for purification of TSH-receptor by affinity chromatography 111
Iodine and thyroid dysfunction in uremia 109
Interference of thyroglobulin in TSAb detection by radio-receptor assay 105
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? 101
LACK OF NOCTURNAL SERUM THYROTROPIN (TSH) SURGE IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING REGULAR MAINTENANCE HEMOFILTRATION - A CASE OF CENTRAL HYPOTHYROIDISM 99
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy 97
GH secretion is impaired in patients with primary hyperparathyroidism 93
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 85
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 84
Selenium in the Treatment of Thyroid Diseases 80
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 79
null 62
Thyroid autoimmunity and endemic goiter 60
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 57
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 56
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy 42
2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction 34
Orbital Cobalt Radiotherapy and Systemic or Retrobulbar Corticosteroids for Graves’ Ophthalmopathy 33
Graves’ disease and Turner’s syndrome 33
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic 33
Measurement of thyroid cell surface antibodies by radioassay using human cultured thyroid cells 32
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: A 2015 Italian Society of Endocrinology Consensus Statement 24
Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH 22
Real-life data on the impact of medical therapy for amiodarone-induced thyrotoxicosis on CV events and hospitalizations 16
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 16
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 12
Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity 12
Studies on thyroid cell surface antigens using cultured human thyroid cells 12
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct 8
Teprotumumab for Graves??? orbitopathy and ototoxicity: moving problems from eyes to ears? 4
Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis 2
Totale 2.022
Categoria #
all - tutte 6.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020293 32 15 30 20 25 43 32 23 27 12 25 9
2020/2021121 8 6 7 9 3 4 13 14 11 16 16 14
2021/2022324 8 10 7 30 51 36 8 11 27 37 32 67
2022/2023567 70 89 32 47 51 54 7 42 134 2 31 8
2023/2024225 10 18 27 12 26 56 23 8 3 6 11 25
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 2.022